Resources
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
On June 22-23, we were at the annual Becker’s Spine, Ortho and Pain conference in Chicago and talking about how we’re demonstrating that measured, precise and pre-emptive care generates real ROI. Interested in learning more or furthering our discussions? Contact us at info@om1.com.
At the forefront of a growing movement towards value-based care, orthopaedic surgeons are facing increasing pressure to make better decisions based on outcomes; to assume greater risk for the cost of joint replacement patient care; and to reduce overall costs while demonstrating quality improvement. Join us for a webinar addressing emerging initiatives, technologies and best[…]
by Joyce Frieden, News Editor, MedPage Today, April 28, 2017 WASHINGTON — Measuring outcomes for heart disease treatment in the general population won’t do much good if researchers can’t agree on a single definition of a particular disease or on which outcomes are worth measuring. That’s why a group of interested organizations is developing a common[…]
OM1 uses predictive analytics to provide better outcomes for patients Dylan Martin – Staff Writer, Tech – 4/6/17 @10:20am in Tech A big data healthcare startup based in Cambridge has come out of stealth mode with a $15 million funding round led by local venture capital firm General Catalyst. The startup, called OM1, was spun out[…]
